Search

Cary Ellen Wehner

Examiner (ID: 13799, Phone: (571)272-4715 , Office: P/3993 )

Most Active Art Unit
3303
Art Unit(s)
3616, 2876, 2303, 3303, 3732, 3993, 3736
Total Applications
2640
Issued Applications
2202
Pending Applications
182
Abandoned Applications
255

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20650461 [patent_doc_number] => 20260102472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-04-16 [patent_title] => SEMAGLUTIDE IN MEDICAL THERAPY [patent_app_type] => utility [patent_app_number] => 19/422732 [patent_app_country] => US [patent_app_date] => 2025-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11832 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19422732 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/422732
SEMAGLUTIDE IN MEDICAL THERAPY Dec 16, 2025 Pending
Array ( [id] => 20541169 [patent_doc_number] => 20260048057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-02-19 [patent_title] => ANTI-ISCHEMIC COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 19/369023 [patent_app_country] => US [patent_app_date] => 2025-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19369023 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/369023
ANTI-ISCHEMIC COMPOSITIONS Oct 23, 2025 Pending
Array ( [id] => 20134951 [patent_doc_number] => 20250241995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-31 [patent_title] => METHOD OF USING A GIP/GLP1 CO-AGONIST FOR DIABETES [patent_app_type] => utility [patent_app_number] => 19/098553 [patent_app_country] => US [patent_app_date] => 2025-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19605 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19098553 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/098553
Method of using a GIP/GLP1 co-agonist for diabetes Apr 1, 2025 Issued
Array ( [id] => 19930352 [patent_doc_number] => 12303545 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-20 [patent_title] => Polypeptide with anti- [patent_app_type] => utility [patent_app_number] => 18/824970 [patent_app_country] => US [patent_app_date] => 2024-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 0 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18824970 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/824970
Polypeptide with anti- Sep 4, 2024 Issued
Array ( [id] => 19601090 [patent_doc_number] => 20240391970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-28 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF FUNGAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/670613 [patent_app_country] => US [patent_app_date] => 2024-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7018 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18670613 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/670613
COMPOSITIONS AND METHODS FOR TREATMENT OF FUNGAL INFECTIONS May 20, 2024 Pending
Array ( [id] => 19845285 [patent_doc_number] => 20250090636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-20 [patent_title] => H3.3 CTL PEPTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/667792 [patent_app_country] => US [patent_app_date] => 2024-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16044 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18667792 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/667792
H3.3 CTL PEPTIDES AND USES THEREOF May 16, 2024 Pending
Array ( [id] => 19601073 [patent_doc_number] => 20240391953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-28 [patent_title] => TUMOR ASSOCIATED MONOCYTE/MACROPHAGE BINDING PEPTIDE AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/652429 [patent_app_country] => US [patent_app_date] => 2024-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55928 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18652429 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/652429
TUMOR ASSOCIATED MONOCYTE/MACROPHAGE BINDING PEPTIDE AND METHODS OF USE THEREOF Apr 30, 2024 Pending
Array ( [id] => 20757141 [patent_doc_number] => 12649900 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-06-09 [patent_title] => Photostabilized compositions and a method for stabilizing photosensitive components [patent_app_type] => utility [patent_app_number] => 18/602421 [patent_app_country] => US [patent_app_date] => 2024-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 716 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18602421 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/602421
Photostabilized compositions and a method for stabilizing photosensitive components Mar 11, 2024 Issued
Array ( [id] => 20413004 [patent_doc_number] => 12496266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-16 [patent_title] => Skin care product with protein matrix [patent_app_type] => utility [patent_app_number] => 18/594290 [patent_app_country] => US [patent_app_date] => 2024-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 30 [patent_no_of_words] => 2353 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18594290 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/594290
Skin care product with protein matrix Mar 3, 2024 Issued
Array ( [id] => 19246835 [patent_doc_number] => 20240197819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => METHODS OF TREATING ALZHEIMERS DISEASE [patent_app_type] => utility [patent_app_number] => 18/417206 [patent_app_country] => US [patent_app_date] => 2024-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16101 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18417206 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/417206
Methods of treating Alzheimers disease Jan 18, 2024 Issued
Array ( [id] => 19846742 [patent_doc_number] => 20250092093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-20 [patent_title] => Androgen receptor protein degradation-inducing peptides for prostate cancer treatment [patent_app_type] => utility [patent_app_number] => 18/470073 [patent_app_country] => US [patent_app_date] => 2023-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3638 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18470073 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/470073
Androgen receptor protein degradation-inducing peptides for prostate cancer treatment Dec 30, 2023 Pending
Array ( [id] => 19318306 [patent_doc_number] => 20240239848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => HOLOTHURIAN-DERIVED ACTIVE PEPTIDE WITH IMMUNE ACTIVITY, PREPARATION METHOD AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/396269 [patent_app_country] => US [patent_app_date] => 2023-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3470 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18396269 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/396269
HOLOTHURIAN-DERIVED ACTIVE PEPTIDE WITH IMMUNE ACTIVITY, PREPARATION METHOD AND APPLICATION THEREOF Dec 25, 2023 Pending
Array ( [id] => 19112776 [patent_doc_number] => 20240124526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => INSULIN LIKE GROWTH FACTOR BINDING PROTEIN BIOACTIVE PEPTIDE FRAGMENTS [patent_app_type] => utility [patent_app_number] => 18/394401 [patent_app_country] => US [patent_app_date] => 2023-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17559 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18394401 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/394401
Insulin like growth factor binding protein bioactive peptide fragments Dec 21, 2023 Issued
Array ( [id] => 19232202 [patent_doc_number] => 20240189393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-13 [patent_title] => COMPOUNDS FOR USE IN INDUCING MYOCARDIAL PERFUSION RECOVERY [patent_app_type] => utility [patent_app_number] => 18/541847 [patent_app_country] => US [patent_app_date] => 2023-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6717 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18541847 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/541847
COMPOUNDS FOR USE IN INDUCING MYOCARDIAL PERFUSION RECOVERY Dec 14, 2023 Pending
Array ( [id] => 20818513 [patent_doc_number] => 12673974 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-07-07 [patent_title] => Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases [patent_app_type] => utility [patent_app_number] => 18/527006 [patent_app_country] => US [patent_app_date] => 2023-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 57728 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 358 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18527006 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/527006
ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES Nov 30, 2023 Issued
Array ( [id] => 19960369 [patent_doc_number] => 12329841 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-17 [patent_title] => Odorant-binding protein compositions, methods and uses thereof [patent_app_type] => utility [patent_app_number] => 18/520428 [patent_app_country] => US [patent_app_date] => 2023-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1811 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18520428 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/520428
Odorant-binding protein compositions, methods and uses thereof Nov 26, 2023 Issued
Array ( [id] => 19049357 [patent_doc_number] => 20240091326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => Treatment of Glaucoma by Neuroprotection [patent_app_type] => utility [patent_app_number] => 18/518981 [patent_app_country] => US [patent_app_date] => 2023-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1336 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18518981 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/518981
Treatment of Glaucoma by Neuroprotection Nov 24, 2023 Pending
Array ( [id] => 19032547 [patent_doc_number] => 20240082362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => GROWTH HORMONE ANTAGONIST AND ANTI-CANCER COMPOSITION COMBINATION THERAPY [patent_app_type] => utility [patent_app_number] => 18/510327 [patent_app_country] => US [patent_app_date] => 2023-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7667 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18510327 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/510327
GROWTH HORMONE ANTAGONIST AND ANTI-CANCER COMPOSITION COMBINATION THERAPY Nov 14, 2023 Abandoned
Array ( [id] => 19001951 [patent_doc_number] => 20240066022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-29 [patent_title] => DIIODOHYDROXYQUINOLINE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION [patent_app_type] => utility [patent_app_number] => 18/387450 [patent_app_country] => US [patent_app_date] => 2023-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9025 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18387450 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/387450
DIIODOHYDROXYQUINOLINE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION Nov 5, 2023 Abandoned
Array ( [id] => 19112804 [patent_doc_number] => 20240124554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => VEGF TRAPS AND MINI-TRAPS AND METHODS FOR TREATING OCULAR DISORDERS AND CANCER [patent_app_type] => utility [patent_app_number] => 18/482589 [patent_app_country] => US [patent_app_date] => 2023-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20427 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18482589 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/482589
VEGF TRAPS AND MINI-TRAPS AND METHODS FOR TREATING OCULAR DISORDERS AND CANCER Oct 5, 2023 Pending
Menu